<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Dev Biol</journal-id><journal-title>BMC Developmental Biology</journal-title><issn pub-type="epub">1471-213X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-213X-5-9</article-id><article-id pub-id-type="pmid">15918910</article-id><article-id pub-id-type="doi">10.1186/1471-213X-5-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title> Creatine synthesis and transport during rat embryogenesis: Spatiotemporal expression of AGAT, GAMT and CT1</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Braissant</surname><given-names>Olivier</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Olivier.Braissant@chuv.ch</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Henry</surname><given-names>Hugues</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Hugues.Henry@chuv.ch</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Villard</surname><given-names>Anne-Marie</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Olivier.Braissant@chuv.ch</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Speer</surname><given-names>Oliver</given-names></name><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><email>Oliver.Speer@molbio.unizh.ch</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Wallimann</surname><given-names>Theo</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>Theo.Wallimann@cell.biol.ethz.ch</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Bachmann</surname><given-names>Claude</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Claude.Bachmann@chuv.ch</email></contrib></contrib-group><aff id="I1"><label>1</label>Clinical Chemistry Laboratory, University Hospital, CH-1011 Lausanne, Switzerland</aff><aff id="I2"><label>2</label>Institute of Cell Biology, Swiss Federal Institute of Technology, CH-8093 Z&#x000fc;rich, Switzerland</aff><aff id="I3"><label>3</label>Institute of Molecular Biology, University of Zurich, CH-8057 Z&#x000fc;rich, Switzerland</aff><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="epub"><day>26</day><month>5</month><year>2005</year></pub-date><volume>5</volume><fpage>9</fpage><lpage>9</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-213X/5/9"/><history><date date-type="received"><day>16</day><month>3</month><year>2005</year></date><date date-type="accepted"><day>26</day><month>5</month><year>2005</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2005 Braissant et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2005</copyright-year><copyright-holder>Braissant et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Braissant Olivier Olivier.Braissant@chuv.ch </dc:author><dc:title> Creatine synthesis and transport during rat embryogenesis: Spatiotemporal expression of AGAT, GAMT and CT1 </dc:title><dc:date>2005</dc:date><dcterms:bibliographicCitation>BMC Developmental Biology 5(1): 9-. (2005)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-213X(2005)5:1&#x0003c;9&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-213X</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Creatine (Cr) is synthesized by a two-step mechanism involving arginine:glycine amidinotransferase (AGAT) and guanidinoacetate methyltransferase (GAMT), and is taken up by cells through a specific Cr transporter, CT1. Recently, genetic defects of this pathway have been described, that lead to Cr deficiency, neurological symptoms in early infancy and severe neurodevelopmental delay. To investigate the involvement of Cr synthesis and uptake pathways during embryonic development, we determined the spatiotemporal expression of AGAT, GAMT and CT1 during the rat embryogenesis, at the mRNA and protein level.</p></sec><sec><title>Results</title><p>We show that AGAT and GAMT are expressed in hepatic primordium as soon as 12.5 days, then progressively acquire their adult pattern of expression, with high levels of AGAT in kidney and pancreas, and high levels of GAMT in liver and pancreas. AGAT and CT1 are prominent in CNS, skeletal muscles and intestine, where they appear earlier than GAMT. High levels of CT1 are found in epithelia.</p></sec><sec><title>Conclusion</title><p>Our results suggest that de novo synthesis of Cr by AGAT and GAMT, as well as cellular Cr uptake by CT1, are essential during embryonic development. This work provides new clues on how creatine can be provided to developing tissues, and suggests that Cr deficiencies might induce irreversible damages already in utero, particularly on the nervous system.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Central nervous system (CNS) is the main organ affected in patients suffering from creatine (Cr) deficiency syndromes due either to AGAT, GAMT or CT1 deficiency [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. As recently described, these patients present neurological symptoms in early infancy and show severe neurodevelopmental delay [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. All three deficiencies are characterized by an absence, or a severe decrease, of Cr in CNS [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>].</p><p>The Cr / phosphocreatine (P-Cr) / creatine kinase (CK) system is essential for the buffering and transport of high energy phosphates [<xref ref-type="bibr" rid="B9">9</xref>]. Cr is taken up by food, or synthesized endogenously by a two-step mechanism involving L-arginine:glycine amidinotransferase (AGAT) and S-adenosyl-L-methionine:N-guanidinoacetate methyltransferase (GAMT). Cr is taken up by cells through CT1, a specific Cr transporter belonging to the Na<sup>+</sup>-dependent neurotransmitter transporter family. In adult mammals, AGAT is predominantly expressed in kidney and pancreas, and GAMT is mainly localized in liver and pancreas. In addition, both enzymes are also expressed in various other tissues, albeit at lower levels. The highest expression of CT1 is found in kidney, heart and skeletal muscle (see [<xref ref-type="bibr" rid="B10">10</xref>] and references therein). Cr synthesis has been observed in CNS [<xref ref-type="bibr" rid="B11">11</xref>]. AGAT and GAMT mRNAs have been revealed in neurons, astrocytes and oligodendrocytes [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. By contrast, CT1 has been found in neurons, oligodendrocytes and microcapillary endothelial cells, but is not detectable in astrocytes [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B18">18</xref>]. Cr plays an essential role in CNS, where it is involved in Na<sup>+</sup>-K<sup>+</sup>-ATPase activity, neurotransmitter release, maintenance of membrane potentials, Ca<sup>++ </sup>homeostasis or restoration of ion gradients (for a review, see [<xref ref-type="bibr" rid="B10">10</xref>]). We have further shown recently that Cr might be involved in axonal growth [<xref ref-type="bibr" rid="B19">19</xref>]. Cr poorly crosses the blood brain barrier of rodents [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]; high doses of Cr given over a long period of treatment only partially replenish brain Cr of AGAT and GAMT deficient patients [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. It has thus been suggested that the postnatal and adult CNS might depend, at least for a part of its needs, on its own Cr synthesis [<xref ref-type="bibr" rid="B13">13</xref>]. This is however in contradiction with the fact that CT1 deficient patients, who should express AGAT and GAMT correctly in their CNS, are nevertheless depleted in intracerebral Cr stores [<xref ref-type="bibr" rid="B22">22</xref>].</p><p>Little information is available on AGAT, GAMT and CT1 in embryonic development. AGAT (mRNA) and GAMT (protein) were found in whole extracts of the developing mouse embryo [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. CT1 mRNA has been shown in the E14 rat embryo, in the entire neuraxis as well as in non-neural tissue [<xref ref-type="bibr" rid="B15">15</xref>]. The materno-fetal transport of Cr has been demonstrated [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. As Cr deficiencies lead to severe developmental delay, our aim was to investigate at what time and in which tissues the system for Cr synthesis and transport is expressed during embryonic development. We determined therefore the tissue distribution of AGAT, GAMT and CT1 gene expression in rat embryos aged of 12.5, 15.5 and 18.5 days, at mRNA and protein level using in situ hybridization and immunohistochemistry respectively.</p></sec><sec><title>Results</title><p>The developmental expression of AGAT, GAMT and CT1 genes was analyzed in E12.5, E15.5 and E18.5 rat embryos at the mRNA and protein levels. For each embryonic stage, patterns of AGAT, GAMT and CT1 expression were validated by <bold>i</bold>) the specificity of anti-AGAT, anti-GAMT and anti-CT1 antibodies (Figure <xref ref-type="fig" rid="F1">1</xref>), <bold>ii</bold>) the specificity of in situ hybridization probes (Figure <xref ref-type="fig" rid="F3">3</xref> and [<xref ref-type="bibr" rid="B13">13</xref>]), and <bold>iii</bold>) the remarkable coherence between in situ hybridization (mRNA, blue) and immunohistochemistry (protein, red) stainings (see Figures <xref ref-type="fig" rid="F3">3</xref> and <xref ref-type="fig" rid="F4">4</xref> for E12.5, Figures <xref ref-type="fig" rid="F5">5</xref> and <xref ref-type="fig" rid="F6">6</xref> for E15.5, Figures <xref ref-type="fig" rid="F7">7</xref> and <xref ref-type="fig" rid="F8">8</xref> for E18.5). Brain structures enlarged in Figures <xref ref-type="fig" rid="F3">3</xref> to <xref ref-type="fig" rid="F8">8</xref> (neocortical epithelium, choroids plexus) are illustrated in Figure <xref ref-type="fig" rid="F2">2</xref> at lower magnification.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Specificity of the anti-AGAT, anti-GAMT and anti-CT1 antibodies</bold>. Western blot analysis of cell extract from rat kidney, by anti-AGAT, anti-GAMT and anti-CT1 antibodies. 10 &#x003bc;g of proteins were loaded in each lane. MM is the molecular mass marker.</p></caption><graphic xlink:href="1471-213X-5-9-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Neocortex of the rat embryo at E12.5, E15.5 and E18.5</bold>. Hematoxylin staining. <bold>A</bold>: E12.5. <bold>B</bold>: E15.5. <bold>C</bold>: E18.5. Neocortical and plexus choroid structures depicted by rectangles in <bold>A</bold>, <bold>B </bold>and <bold>C </bold>are enlarged in Figures 3 A,E,I; 4 B,E,H; 5 A,B,F,G,K,L; 6 A,E,I; 7 A,B,M,N; and 8 A,B. <bold>CP</bold>: choroid plexus; <bold>LV</bold>: lateral ventricle; <bold>N</bold>: neocortex; <bold>P</bold>: pallidum. Bar : 200 &#x003bc;m.</p></caption><graphic xlink:href="1471-213X-5-9-2"/></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Expression of the AGAT, GAMT and CT1 mRNAs in the E12.5 rat embryo</bold>. In situ hybridization (mRNA, blue signal) experiments performed with antisense probes against AGAT (<bold>A-C</bold>), GAMT (<bold>E-G</bold>) and CT1 (<bold>I-K</bold>) mRNAs, and with the sense counterpart probes for AGAT (<bold>D</bold>), GAMT (<bold>H</bold>) and CT1 (<bold>L</bold>). <bold>A,E,I </bold>and <bold>D,H,L</bold>: dorsal telencephalic neuroepithelium; <bold>B,F,J</bold>: somites; <bold>C,G,K</bold>: liver. Bar : 100 &#x003bc;m.</p></caption><graphic xlink:href="1471-213X-5-9-3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Expression of the AGAT, GAMT and CT1 proteins in the E12.5 rat embryo</bold>. Immunohistochemistry (protein, red signal) experiments performed with anti-AGAT (<bold>A-C</bold>), anti-GAMT (<bold>D-F</bold>) and anti-CT1 (<bold>G-I</bold>) antibodies. <bold>A,D,G </bold>: coronal section through hindbrain; <bold>B,E,H</bold>: dorsal telencephalic neuroepithelium; <bold>C,F,I</bold>: liver. Bar : <bold>A,D,G</bold>: 200 &#x003bc;m; <bold>B,C,E,F,H,I</bold>: 100 &#x003bc;m.</p></caption><graphic xlink:href="1471-213X-5-9-4"/></fig><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>Expression of the AGAT, GAMT and CT1 mRNAs in the E15.5 rat embryo</bold>. In situ hybridization (mRNA, blue signal) experiments performed with antisense probes against AGAT (<bold>A-E</bold>), GAMT (<bold>F-J</bold>) and CT1 (<bold>K-O</bold>) mRNAs. <bold>A,F,K</bold>: neocortical neuroepithelium; <bold>B,G,L</bold>: choroid plexus; <bold>C,H,M</bold>: gonadal primordium; <bold>D,I,N</bold>: kidney; <bold>E,J,O</bold>: liver. Bar : 100 &#x003bc;m.</p></caption><graphic xlink:href="1471-213X-5-9-5"/></fig><fig position="float" id="F6"><label>Figure 6</label><caption><p><bold>Expression of the AGAT, GAMT and CT1 proteins in the E15.5 rat embryo</bold>. Immunohistochemistry (protein, red signal) experiments performed with anti-AGAT (<bold>A-D</bold>), anti-GAMT (<bold>E-H</bold>) and anti-CT1 (<bold>I-L</bold>) antibodies. <bold>A,E,I</bold>: neocortical neuroepithelium; <bold>B,F,J</bold>: gonadal primordium; <bold>C,G,L</bold>: kidney; <bold>D,H,L</bold>: liver. Bar : 100 &#x003bc;m.</p></caption><graphic xlink:href="1471-213X-5-9-6"/></fig><fig position="float" id="F7"><label>Figure 7</label><caption><p><bold>Expression of AGAT and GAMT in the E18.5 rat embryo</bold>. In situ hybridization (mRNA, blue signal) and immunohistochemistry (protein, red signal) experiments against AGAT (<bold>A-L</bold>) and GAMT (<bold>M-X</bold>). <bold>A,B,M,N</bold>: neocortical neuroepithelium; <bold>C,D,O,P</bold>: skeletal muscle; <bold>E,F,Q,R</bold>: kidney; <bold>G,H,S,T</bold>: liver; <bold>I,J,U,V</bold>: pancreas; <bold>K,L,W,X</bold>: intestine. Bar : 100 &#x003bc;m.</p></caption><graphic xlink:href="1471-213X-5-9-7"/></fig><fig position="float" id="F8"><label>Figure 8</label><caption><p><bold>Expression of CT1 in the E18.5 rat embryo</bold>. In situ hybridization (mRNA, blue signal) and immunohistochemistry (protein, red signal) experiments against CT1. <bold>A,B</bold>: neocortical neuroepithelium; <bold>C,D</bold>: skin; <bold>E,F</bold>: kidney; <bold>G,H</bold>: intestine. Bar : 100 &#x003bc;m.</p></caption><graphic xlink:href="1471-213X-5-9-8"/></fig><fig position="float" id="F9"><label>Figure 9</label><caption><p><bold>Expression of AGAT mRNA in the main tissues of the rat embryo.</bold> i : isolated cells ; - : absent ; &#x000b1; : barely detectable ; + : moderate expression, ++ : strong expression, +++ : very strong expression. More differentiated structures of older stages are connected with the &#x0201c;{&#x0201c; sign to the younger structure from which they originate. </p></caption><graphic xlink:href="1471-213X-5-9-9"/></fig><fig position="float" id="F10"><label>Figure 10</label><caption><p><bold>Expression of GAMT mRNA in the main tissues of the rat embryo.</bold> i : isolated cells ; - : absent ; &#x000b1; : barely detectable ; + : moderate expression, ++ : strong expression, +++ : very strong expression. More differentiated structures of older stages are connected with the &#x0201c;{&#x0201c; sign to the younger structure from which they originate. </p></caption><graphic xlink:href="1471-213X-5-9-10"/></fig><fig position="float" id="F11"><label>Figure 11</label><caption><p><bold>Expression of CT1 mRNA in the main tissues of the rat embryo.</bold> i : isolated cells ; - : absent ; &#x000b1; : barely detectable ; + : moderate expression, ++ : strong expression, +++ : very strong expression. More differentiated structures of older stages are connected with the &#x0201c;{&#x0201c; sign to the younger structure from which they originate.</p></caption><graphic xlink:href="1471-213X-5-9-11"/></fig><sec><title>E12.5 rat embryos</title><p>AGAT was detected in all parts of the E12.5 central nervous system (Figure <xref ref-type="fig" rid="F9">9</xref>; Figures <xref ref-type="fig" rid="F3">3A</xref>; <xref ref-type="fig" rid="F4">4A</xref> and <xref ref-type="fig" rid="F4">4B</xref>). Highest levels were detected in the middle part of somites (Figure <xref ref-type="fig" rid="F3">3B</xref>) as well as in the hepatic primordium (Figures <xref ref-type="fig" rid="F3">3C</xref>; <xref ref-type="fig" rid="F4">4C</xref>). AGAT was also detected in the wall of dorsal aorta, but was not detectable in epidermis and heart (Figure <xref ref-type="fig" rid="F9">9</xref>).</p><p>GAMT at E12.5 was detectable in the hepatic primordium only (Figures <xref ref-type="fig" rid="F3">3G</xref>; <xref ref-type="fig" rid="F4">4F</xref>), with all other tissues being negative (Figure <xref ref-type="fig" rid="F10">10</xref>, Figures <xref ref-type="fig" rid="F3">3E&#x02013;F</xref>; <xref ref-type="fig" rid="F4">4D</xref> and <xref ref-type="fig" rid="F4">4E</xref>).</p><p>CT1 was expressed by all parts of the E12.5 CNS (Figure <xref ref-type="fig" rid="F11">11</xref>; Figures <xref ref-type="fig" rid="F3">3I</xref>; <xref ref-type="fig" rid="F4">4G</xref> and <xref ref-type="fig" rid="F4">4E</xref>). In contrast to AGAT which was restricted to the central part of somites, CT1 was found expressed throughout the whole somites (Figure <xref ref-type="fig" rid="F3">3J</xref>). CT1 was also present in the dorsal aorta and the hepatic primordium (Figures <xref ref-type="fig" rid="F3">3K</xref>; <xref ref-type="fig" rid="F4">4I</xref>). At E12.5, CT1 was not detectable in epidermis and heart (Figure <xref ref-type="fig" rid="F11">11</xref>).</p><p>In situ hybridization control sections hybridized with the respective AGAT, GAMT and CT1 sense probes were negative (Figure <xref ref-type="fig" rid="F3">3D</xref>, <xref ref-type="fig" rid="F3">3H</xref> and <xref ref-type="fig" rid="F3">3L</xref>).</p></sec><sec><title>E15.5 rat embryos</title><p>AGAT was expressed in most regions of the E15.5 CNS, with increased levels detected in isolated cells throughout the developing brain (Figure <xref ref-type="fig" rid="F9">9</xref>; Figures <xref ref-type="fig" rid="F5">5A</xref>; <xref ref-type="fig" rid="F6">6A</xref>). AGAT was not detected in choroid plexus (Figure <xref ref-type="fig" rid="F5">5B</xref>), nor in the dorsal root ganglia (Figure <xref ref-type="fig" rid="F9">9</xref>). High levels of AGAT were observed in skeletal muscles and primordia of gonads (Figures <xref ref-type="fig" rid="F5">5C</xref>; <xref ref-type="fig" rid="F6">6B</xref>), and AGAT was also detected in caudal somites (as shown earlier at E12.5, Fig. <xref ref-type="fig" rid="F3">3B</xref>), liver (Figures <xref ref-type="fig" rid="F5">5E</xref>; <xref ref-type="fig" rid="F6">6D</xref>) and pancreas, with, as in CNS, higher levels in isolated cells (Figure <xref ref-type="fig" rid="F9">9</xref>). At E15.5, AGAT could not be detected in kidney (Figures <xref ref-type="fig" rid="F5">5D</xref>; <xref ref-type="fig" rid="F6">6C</xref>), nor in all the remaining tissues observed (Figure <xref ref-type="fig" rid="F9">9</xref>).</p><p>GAMT could not be detected in most of the E15.5 CNS (Figures <xref ref-type="fig" rid="F5">5F</xref>; <xref ref-type="fig" rid="F6">6E</xref>), with the exception of striatum and pons (Figure <xref ref-type="fig" rid="F10">10</xref>). High levels of GAMT were found in liver (Figures <xref ref-type="fig" rid="F5">5J</xref>; <xref ref-type="fig" rid="F6">6H</xref>), and it was also expressed in pancreas. All the remaining tissues observed were negative for GAMT at E15.5 (Figure <xref ref-type="fig" rid="F10">10</xref>).</p><p>CT1 was strongly expressed in most of the E15.5 CNS (Figure <xref ref-type="fig" rid="F11">11</xref>; Figures <xref ref-type="fig" rid="F5">5K</xref>; <xref ref-type="fig" rid="F6">6I</xref>). CT1 was detected in choroid plexus (Figure <xref ref-type="fig" rid="F5">5L</xref>). CT1 was observed in skeletal muscles and caudal somites, as well as in kidney (Figures <xref ref-type="fig" rid="F5">5N</xref>; <xref ref-type="fig" rid="F6">6K</xref>), lung, stomach and intestine epithelial cells (Figure <xref ref-type="fig" rid="F11">11</xref>). CT1 could not be detected in gonads (Figures <xref ref-type="fig" rid="F5">5M</xref>; <xref ref-type="fig" rid="F6">6J</xref>), liver (Figures <xref ref-type="fig" rid="F5">5O</xref>; <xref ref-type="fig" rid="F6">6L</xref>) and pancreas, nor in all the remaining tissues observed (Figure <xref ref-type="fig" rid="F11">11</xref>).</p></sec><sec><title>E18.5 rat embryos</title><p>AGAT mRNA was expressed in most regions of the E18.5 CNS (Figure <xref ref-type="fig" rid="F9">9</xref>). Interestingly, high levels of AGAT mRNA were detected in endothelial cells of the developing cerebral capillaries (Figure <xref ref-type="fig" rid="F7">7A</xref>), but was absent from choroid plexus (Figure <xref ref-type="fig" rid="F9">9</xref>). A high expression of AGAT, both at the mRNA and protein levels, was also detected in skeletal muscle (Figure <xref ref-type="fig" rid="F7">7C,D</xref>), kidney (Figure <xref ref-type="fig" rid="F7">7E,F</xref>) and pancreas (Figure <xref ref-type="fig" rid="F7">7I,J</xref>), while a lower level of AGAT was found in liver (Figure <xref ref-type="fig" rid="F7">7G,H</xref>) and intestine epithelial cells (Figure <xref ref-type="fig" rid="F7">7K,L</xref>). At E18.5, AGAT could not be detected in epidermis and dermis, in olfactory epithelium, trachea and lung, nor in stomach and heart (Figure <xref ref-type="fig" rid="F9">9</xref>).</p><p>GAMT was expressed in neocortex (Figure <xref ref-type="fig" rid="F7">7M,N</xref>), hippocampus, striatum, pallidum and spinal cord, but could not be detected in other structures of the E18.5 brain (Figure <xref ref-type="fig" rid="F10">10</xref>). GAMT was absent from endothelial cells of cerebral capillaries, as well as from choroid plexus. In peripheral tissues, the highest expression of GAMT, both at the mRNA and protein levels, was found in skeletal muscles (Figure <xref ref-type="fig" rid="F7">7O,P</xref>) and liver (Figure <xref ref-type="fig" rid="F7">7S,T</xref>), while it was also present in pancreas (Figure <xref ref-type="fig" rid="F7">7U,V</xref>) and intestinal epithelial cells (Figure <xref ref-type="fig" rid="F7">7W,X</xref>). GAMT could not be detected in the E18.5 kidney (Figure <xref ref-type="fig" rid="F7">7Q,R</xref>), nor in all the remaining tissues observed (Figure <xref ref-type="fig" rid="F10">10</xref>).</p><p>CT1 was highly expressed in most regions of the E18.5 CNS, both at the mRNA and protein levels (Figure <xref ref-type="fig" rid="F11">11</xref>, Figure <xref ref-type="fig" rid="F8">8A,B</xref>). CT1 was absent from endothelial cells of cerebral capillaries, but highly expressed in choroid plexus (Figure <xref ref-type="fig" rid="F11">11</xref>). Most peripheral tissues expressed CT1 (Figure <xref ref-type="fig" rid="F11">11</xref>), as illustrated for epidermis and dermis (Figure <xref ref-type="fig" rid="F8">8C,D</xref>), kidney (Figure <xref ref-type="fig" rid="F8">8E,F</xref>) and intestine epithelial cells (Figure <xref ref-type="fig" rid="F8">8G,H</xref>). However, no signal for CT1 could be detected in liver and pancreas (Figure <xref ref-type="fig" rid="F11">11</xref>).</p></sec></sec><sec><title>Discussion</title><sec><title>Creatine in embryonic development</title><p>The Cr / P-Cr / CK system plays an essential role in energy homeostasis during the vertebrate embryonic development, with prominent activities in tissues such as developing CNS and muscles [<xref ref-type="bibr" rid="B9">9</xref>]. CK genes are expressed very early in many structures of the vertebrate embryo [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>], whereas Cr concentration between 2 and 4 mmol/kg wet weight are found in the whole rat fetus, depending on the developmental stage [<xref ref-type="bibr" rid="B29">29</xref>]. In CNS, Cr concentration between 5 and 8 mmol/kg wet weight have been found in rat and human fetus, depending on the gestational stage [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>]. Parts of the developmental needs for Cr can be fulfilled by the active transport of Cr from the mother to the embryo [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B31">31</xref>]. GAMT knock-out mice, which develop biochemical alterations comparable to those found in human GAMT deficient patients, present an increase in perinatal mortality [<xref ref-type="bibr" rid="B24">24</xref>]. It is not known however whether alterations in Cr pathways, as found in AGAT, GAMT or CT1 deficiencies, impairs the development of the embryo.</p></sec><sec><title>AGAT and GAMT for de novo synthesis of Cr in the embryo</title><p>As both substrates arginine (for AGAT) and S-adenosylmethionine (for GAMT) are available for most tissues (including liver, brain and muscle) during the mammalian embryonic development [<xref ref-type="bibr" rid="B32">32</xref>-<xref ref-type="bibr" rid="B34">34</xref>], our study suggests that the rat embryo might be able of its own Cr synthesis as soon as E12.5, in the hepatic primordium which expresses both AGAT and GAMT. From E12.5 to E18.5, both enzymes then progressively acquire their expression pattern found in aduldhood, with AGAT mainly expressed in kidney and pancreas, and GAMT preferentially localized in liver and pancreas (see [<xref ref-type="bibr" rid="B10">10</xref>] and references therein). As in adulthood however, many other different embryonic tissues retain low levels of AGAT and/or GAMT; we found that skeletal muscles and intestinal epithelial cells at E18.5 are equipped to synthesize their own Cr by expressing both AGAT and GAMT. A few embryonic structures express only AGAT (muscles before E18.5, regions of CNS, blood vessels) suggesting that they have to release the intermediate GAA, that has to be transported to GAMT-expressing cells for Cr synthesis to occur, as it is generally thought between kidney (AGAT) and liver (GAMT) in adult mammals. A few embryonic structures (i.e. somites at E12.5 and E15.5, skeletal muscles at E15.5 and E18.5, gonadal primordium at E15.5) showed a striking and very high expression of AGAT. This might be explained by the strong and positive regulation of AGAT, at the transcriptional level, by thyroid, growth and sex hormones [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>], which do control the embryonic development of somites, skeletal muscles and gonads [<xref ref-type="bibr" rid="B37">37</xref>-<xref ref-type="bibr" rid="B40">40</xref>].</p><p>While this study shows that AGAT is expressed as soon as E12.5 in the whole CNS parenchyme and increases towards E18.5, it demonstrates also that GAMT expression in the developing CNS is delayed, and remains at low levels as compared to AGAT. Adult rat CNS appears to be able of synthesizing its own Cr by expressing AGAT and GAMT in most cell types of the brain [<xref ref-type="bibr" rid="B13">13</xref>]; in contrast, our work suggests that independance of CNS for its own Cr synthesis is probably limited to the end of embryogenesis and restricted to discrete regions of CNS. Thus, the embryonic brain might depend mainly on extra-CNS supply of Cr, be it of maternal origin or synthesized in other tissues of the embryo (see below).</p></sec><sec><title>CT1 for the supply of Cr to embryonic tissues</title><p>From E12.5 to E18.5, most of the embryonic tissues progressively express CT1, allowing cellular Cr uptake. Notable exceptions are liver (apart from a low and transient expression at E12.5) and pancreas, which express GAMT, and endothelial cells of brain capillaries (see below). These results are in accordance with earlier work on the E14 rat embryo [<xref ref-type="bibr" rid="B15">15</xref>]. Highest levels of CT1 are found as soon as E12.5, in tissues requiring high amounts of Cr, like somites, skeletal muscles and CNS. In gonads, CT1 and GAMT appeared at E18.5 only, while AGAT was highly expressed at E15.5 and decreased at E18.5. This is in accordance with their respective expression in the adult reproductive tract [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B41">41</xref>]. CT2, a second potential Cr transporter showing 95% nucleotide identity with the CT1 coding sequence, has been found expressed in testis solely, at the RNA level [<xref ref-type="bibr" rid="B41">41</xref>]. However, CT2 most probably represents a pseudogene, as it cannot be fully translated into a functional protein [<xref ref-type="bibr" rid="B42">42</xref>], suggesting that the needs in Cr of the reproductive tract are fulfilled by CT1, as well as AGAT and GAMT.</p><p>The delayed and low level of GAMT expression during CNS embryogenesis suggests that the embryonic brain might depend on extra-CNS supply of Cr. This is supported by our results on CT1, which is expressed at high levels in the whole embryonic CNS, with a peak at E15.5. Interestingly, CT1 is expressed in the choroid plexus of the rat embryo (E15.5 and E18.5), but not of the adult rat brain [<xref ref-type="bibr" rid="B13">13</xref>]. In contrast, CT1 is absent from endothelial cells of brain capillaries in the embryo, while these cells express it in the adult rat CNS [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. As choroid plexus differentiates earlier than brain capillaries and participates to early trophic supply for CNS [<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref>], one might speculate that before angiogenesis occurs in CNS parenchyme, extra-CNS Cr is supplied from blood to cerebrospinal fluid through the choroid plexus. Cr would then be available for the whole embryonic brain through cerebrospinal fluid circulation [<xref ref-type="bibr" rid="B45">45</xref>] and the observed high levels of CT1 in the developing neuroepithelium, particularly in ependymal epithelium along ventricles (see below CT1 in surface epithelia exposed to amniotic fluid). As brain develops and enlarges, and CNS angiogenesis progresses, the ratio of exchange surfaces in choroid plexus and CNS microcapillaries shifts to predominance of brain microcapillaries [<xref ref-type="bibr" rid="B43">43</xref>-<xref ref-type="bibr" rid="B45">45</xref>]. Thus, at the end of embryonic development and then postnatally, Cr supply to the brain may occur preferentially at microcapillaries, with CT1 being up-regulated in capillary endothelial cells and down-regulated in choroid plexus, as in adulthood [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. It should be emphasized however that supply of Cr from blood to postnatal or adult brain is very likely of less quantitative importance than intra-cerebral Cr synthesis, as astrocytes around blood brain barrier do not express CT1 [<xref ref-type="bibr" rid="B13">13</xref>].</p><p>At E15.5 and E18.5, CT1 was found highly expressed in all epithelia of the rat embryo being in contact with amniotic fluid, i.e. epidermis, olfactory epithelium, trachea, lung, stomach, and intestine. Cr uptake has been confirmed recently in E16 rat embryo intestine [<xref ref-type="bibr" rid="B46">46</xref>]. Amniotic fluid contains significant amounts of Cr (50 to 100 &#x003bc;M in human depending on gestational age [<xref ref-type="bibr" rid="B47">47</xref>]; 320 &#x003bc;M in rat [<xref ref-type="bibr" rid="B46">46</xref>]). It is produced by amniotic cells (at the surface of chorion) and the foetus, and is continuously renewed by oral intake of the foetus and excretion (urine). Amniotic fluid may thus represent an easy way to supply Cr to many structures of the embryo, through epithelial expression of CT1 in embryonic parts where vasculature is not yet fully developed.</p><p>It is known that Cr is also supplied by active transport from the mother to the embryo, accumulating in the chorioallantoic placenta and yolk sac at concentrations higher than found in maternal or fetal blood, then diffusing down its concentration gradient into the fetal circulation [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B31">31</xref>]. Thus previous studies, as well as our data, suggest that materno-fetal transport of Cr and de novo synthesis of Cr in the embryo are both necessary for a normal development to occur.</p></sec><sec><title>In utero consequences of AGAT, GAMT or CT1 deficiencies</title><p>Patients suffering of AGAT, GAMT or CT1 deficiency present neurological symptoms in early infancy and show severe neurodevelopmental delay [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. AGAT and GAMT deficiencies can be treated with oral Cr, which slowly replenishes brain levels of Cr [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B48">48</xref>-<xref ref-type="bibr" rid="B50">50</xref>]. Treatment of CT1 deficient patients with oral Cr does not replenish their CNS Cr level [<xref ref-type="bibr" rid="B51">51</xref>]. Despite developmental improvement and recovery of AGAT and GAMT deficient patients treated with Cr, sequelae to brain development and mental retardation remain [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. For GAMT deficiency, this may be due to the toxicity of the GAA accumulating in CNS. Most patients with AGAT, GAMT or CT1 deficiencies are diagnosed during infancy, and significant damage to their brain occur postnatally. However, AGAT, GAMT and CT1 expression patterns during the rat embryogenesis suggests that some of the irreversible damages observed in Cr deficient patients, lacking either AGAT, GAMT or CT1, may already occur in utero.</p></sec></sec><sec><title>Conclusion</title><p>We have shown that AGAT, GAMT and CT1 are expressed by various tissues throughout the development of the rat embryo. This study suggests that de novo synthesis of Cr and Cr uptake are important for embryonic development. This work provides new clues on how creatine can be provided to developing tissues, and suggests moreover that irreversible damage observed in Cr deficient patients, lacking either AGAT, GAMT or CT1, may already occur in utero.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Preparation of E12.5, E15.5 and E18.5 rat embryos</title><p>All animal procedures were in compliance with the directives of the Swiss Academy of Medical Science. Sprague-Dawley pregnant female rats (Charles River Laboratories, France) were fed a standard chow formula. Embryonic stages of rat embryos were determined from the appearance of vaginal plug in pregnant females. 2 pregnant females were used for each embryonic stage (E12.5: 12.5 days of gestation, 7 embryos; E15.5: 15.5 days of gestation, 5 embryos; E18.5: 18.5 days of gestation, 5 embryos). For each embryonic stage, females were sacrificed by decapitation, and embryos were removed from uterus, rinsed in diethylpyrocarbonate (DEPC)-treated PBS and fixed for 15 h at room temperature in 4% paraformaldehyde in DEPC-treated PBS. Subsequently, embryos were cryoprotected at 4&#x000b0;C in 12% and 18% sucrose in DEPC-treated PBS for 18 h and 24 h respectively, then embedded in tissue-freezing medium (Jung, Nussloch, Germany) and frozen in liquid nitrogen cooled isopentane. Embryos were stored at -80&#x000b0;C until used for cryosections.</p></sec><sec><title>In situ hybridization and immunohistochemistry</title><p>Partial cDNAs of the rat sequences AGAT (nt 182-1314, Gene Bank accession number <ext-link ext-link-type="gen" xlink:href="U07971">U07971</ext-link>), GAMT (nt 131-734, Gene Bank <ext-link ext-link-type="gen" xlink:href="J03588">J03588</ext-link>) and CT1 (nt 901-2544, Gene Bank <ext-link ext-link-type="gen" xlink:href="NM_01738">NM_01738</ext-link>) were used to synthesize antisense and sense digoxigenin-labeled AGAT, GAMT and CT1 riboprobes as described previously [<xref ref-type="bibr" rid="B13">13</xref>]. 12 &#x003bc;m thick cryosections (Leica CM 1800) were prepared for each embryonic stage, which were analyzed by a sensitive technique of non-radioactive in situ hybridization [<xref ref-type="bibr" rid="B52">52</xref>]. Briefly, cryosections were postfixed 10 min in 4% paraformaldehyde in DEPC-treated PBS, washed 2 &#x000d7; 15 min in PBS containing 0.1% fresh DEPC and equilibrated 15 min in 5 &#x000d7; SSC. Sections were hybridized (58&#x000b0;C for 40 h in 5 &#x000d7; SSC, 50% formamide and 40 &#x003bc;g/ml salmon sperm DNA) with the digoxigenin-labeled antisense and sense riboprobes (400 ng/ml) for rat AGAT, GAMT and CT1. Sections were then washed (30 min in 2 &#x000d7; SSC at room temperature, 1 h in 2 &#x000d7; SSC at 65&#x000b0;C, 1 h in 0.1 &#x000d7; SSC at 65&#x000b0;C) and stained with alkaline phosphatase-coupled anti-digoxygenin antibody (Roche, Basel, Switzerland) using nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl-phosphate. The specificity of hybridization was ascertained by the use of sense probes for AGAT, GAMT and CT1 genes having the same length, GC content and digoxigenin incorporation as their antisense counterparts. In each in situ hybridization experiment, a section hybridized with an antisense probe was always followed by an adjacent section hybridized with the corresponding sense control probe. After staining, sections were dehydrated and mounted (Eukit, O. Kindler Co, Freiburg, Germany).</p><p>AGAT, GAMT and CT1 proteins were detected with rabbit polyclonal antibodies, that were made through injection of the following antigenic peptides: AGAT N-terminal amino acids (aa) 62-77 and C-terminal aa 410-423(SwissProt, accession number <ext-link ext-link-type="sprot" xlink:href="P50442">P50442</ext-link>); GAMT aa 27-227(SwissProt, accession number <ext-link ext-link-type="sprot" xlink:href="P10868">P10868</ext-link>); and CT1 N-terminal aa 15-29 (SwissProt, accession number <ext-link ext-link-type="sprot" xlink:href="P28570">P28570</ext-link>). Specific immunoglobulins against AGAT, GAMT and CT1 were obtained by peptide affinity chromatography. These antibodies recognize specific bands for AGAT (46 kDa), GAMT (26 kDa) and CT1 (61 kDa) respectively, by western blotting experiments (Figure <xref ref-type="fig" rid="F1">1</xref>). AGAT, GAMT and CT1 proteins were analyzed by immunohistochemistry on 8 &#x003bc;m thick cryosections using the 3 polyclonal antibodies described above. Briefly, cryosections were postfixed for 1 h in 4%PFA in PBS. Endogenous peroxidase activities were bleached using 1.5% H<sub>2</sub>O<sub>2 </sub>in PBS for 15 min. After blocking 1 h in 1% bovine serum albumin in PBS, anti-AGAT, anti-GAMT and anti-CT1 antibodies were incubated for 1 h at room temperature in the same buffer. Their detection by peroxidase staining was performed using the Histostain Plus Kit (Zymed Laboratories Inc) with aminoethyl carbazole and H<sub>2</sub>O<sub>2</sub>.</p><p>The expression patterns of AGAT, GAMT and CT1 genes observed during the embryonic development were considered specific and validated by (<bold>i</bold>) the excellent correlation, in the multiple embryonic tissues analysed, between the signals observed at the mRNA level by in situ hybridization and at the protein level by immunohistochemistry, (<bold>ii</bold>) the negative signals observed with the in situ hybridization sense probes (see Figure <xref ref-type="fig" rid="F3">3</xref> and [<xref ref-type="bibr" rid="B13">13</xref>]), and (<bold>iii</bold>) by the absence of any labelling in immunohistochemical controls without primary antibodies or in presence of pre-immune serum (data not shown).</p><p>Sections were observed and photographed on an Olympus BX50 microscope equipped with a DP-10 digital camera (Olympus Opticals, Japan). Structures were identified according to [<xref ref-type="bibr" rid="B53">53</xref>-<xref ref-type="bibr" rid="B55">55</xref>], after staining of sections by hematoxylin (see Figure <xref ref-type="fig" rid="F2">2</xref>). In Figures <xref ref-type="fig" rid="F9">9</xref>,<xref ref-type="fig" rid="F10">10</xref> and <xref ref-type="fig" rid="F11">11</xref> semi-quantitative levels of AGAT, GAMT and CT1 mRNA were determined based on ISH experiments, as described [<xref ref-type="bibr" rid="B56">56</xref>]. Levels of transcripts observed by optical microscopy are indicated by - and + signs which however do not represent a strict linear mesure of mRNA.</p></sec></sec><sec><title>List of abbreviations used</title><p>AGAT: arginine:glycine amidinotransferase; CK: creatine kinase; CNS: central nervous system; Cr: creatine; CT1: creatine transporter 1; DEPC: diethylpyrocarbonate; GAMT: guanidinoacetate methyltransferase; P-Cr: phosphocreatine</p></sec><sec><title>Authors' contributions</title><p>OB conceived of the study, wrote the manuscript and performed immunohistochemistry experiments. HH designed and characterized the anti-GAMT and anti-CT1 antibodies, performed the western blotting experiments and participated in the writing of the manuscript. AMV carried out the in situ hybridization and immunohistochemistry experiments. OS designed and characterized the anti-AGAT antibody, and participated in the writing of the manuscript. TW and CB participated in the writing of the manuscript. All authors read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This work was funded by the Swiss National Science Foundation (grants n&#x000b0; 3100-063892 and 3100A0-100778 to OB, HH and CB; n&#x000b0; 3100A0-102075 to TW) and the Swiss Society for Research on Muscle Disease (to TW). Marc Loup and Barbara Eilers are gratefully acknowledged for their excellent technical work.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>St&#x000f6;ckler</surname><given-names>S</given-names></name><name><surname>Holzbach</surname><given-names>U</given-names></name><name><surname>Hanefeld</surname><given-names>F</given-names></name><name><surname>Marquardt</surname><given-names>I</given-names></name><name><surname>Helms</surname><given-names>G</given-names></name><name><surname>Requart</surname><given-names>M</given-names></name><name><surname>H&#x000e4;nicke</surname><given-names>W</given-names></name><name><surname>Frahm</surname><given-names>J</given-names></name></person-group><article-title>Creatine deficiency in the brain: a new, treatable inborn error of metabolism</article-title><source>Pediatr Res</source><year>1994</year><volume>36</volume><fpage>409</fpage><lpage>413</lpage><pub-id pub-id-type="pmid">7808840</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salomons</surname><given-names>GS</given-names></name><name><surname>van Dooren</surname><given-names>SJ</given-names></name><name><surname>Verhoeven</surname><given-names>NM</given-names></name><name><surname>Cecil</surname><given-names>KM</given-names></name><name><surname>Ball</surname><given-names>WS</given-names></name><name><surname>DeGrauw</surname><given-names>TJ</given-names></name><name><surname>Jakobs</surname><given-names>C</given-names></name></person-group><article-title>X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome</article-title><source>Am J Hum Genet</source><year>2001</year><volume>68</volume><fpage>1497</fpage><lpage>1500</lpage><pub-id pub-id-type="pmid">11326334</pub-id><pub-id pub-id-type="doi">10.1086/320595</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Item</surname><given-names>CB</given-names></name><name><surname>St&#x000f6;ckler-Ipsiroglu</surname><given-names>S</given-names></name><name><surname>Stromberger</surname><given-names>C</given-names></name><name><surname>Muhl</surname><given-names>A</given-names></name><name><surname>Alessandri</surname><given-names>MG</given-names></name><name><surname>Bianchi</surname><given-names>MC</given-names></name><name><surname>Tosetti</surname><given-names>M</given-names></name><name><surname>Fornai</surname><given-names>F</given-names></name><name><surname>Cioni</surname><given-names>G</given-names></name></person-group><article-title>Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans</article-title><source>Am J Hum Genet</source><year>2001</year><volume>69</volume><fpage>1127</fpage><lpage>1133</lpage><pub-id pub-id-type="pmid">11555793</pub-id><pub-id pub-id-type="doi">10.1086/323765</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schulze</surname><given-names>A</given-names></name><name><surname>Hess</surname><given-names>T</given-names></name><name><surname>Wevers</surname><given-names>R</given-names></name><name><surname>Mayatepek</surname><given-names>E</given-names></name><name><surname>Bachert</surname><given-names>P</given-names></name><name><surname>Marescau</surname><given-names>B</given-names></name><name><surname>Knopp</surname><given-names>MV</given-names></name><name><surname>De Deyn</surname><given-names>PP</given-names></name><name><surname>Bremer</surname><given-names>HJ</given-names></name><name><surname>Rating</surname><given-names>D</given-names></name></person-group><article-title>Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism</article-title><source>J Pediatr</source><year>1997</year><volume>131</volume><fpage>626</fpage><lpage>631</lpage><pub-id pub-id-type="pmid">9386672</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Battini</surname><given-names>R</given-names></name><name><surname>Leuzzi</surname><given-names>V</given-names></name><name><surname>Carducci</surname><given-names>C</given-names></name><name><surname>Tosetti</surname><given-names>M</given-names></name><name><surname>Bianchi</surname><given-names>MC</given-names></name><name><surname>Item</surname><given-names>CB</given-names></name><name><surname>St&#x000f6;ckler-Ipsiroglu</surname><given-names>S</given-names></name><name><surname>Cioni</surname><given-names>G</given-names></name></person-group><article-title>Creatine depletion in a new case with AGAT deficiency: clinical and genetic study in a large pedigree</article-title><source>Mol Genet Metab</source><year>2002</year><volume>77</volume><fpage>326</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">12468279</pub-id><pub-id pub-id-type="doi">10.1016/S1096-7192(02)00175-0</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeGrauw</surname><given-names>TJ</given-names></name><name><surname>Salomons</surname><given-names>GS</given-names></name><name><surname>Cecil</surname><given-names>KM</given-names></name><name><surname>Chuck</surname><given-names>G</given-names></name><name><surname>Newmeyer</surname><given-names>A</given-names></name><name><surname>Schapiro</surname><given-names>MB</given-names></name><name><surname>Jakobs</surname><given-names>C</given-names></name></person-group><article-title>Congenital creatine transporter deficiency</article-title><source>Neuropediatrics</source><year>2002</year><volume>33</volume><fpage>232</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">12536364</pub-id><pub-id pub-id-type="doi">10.1055/s-2002-36743</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stromberger</surname><given-names>C</given-names></name><name><surname>Bodamer</surname><given-names>OA</given-names></name><name><surname>St&#x000f6;ckler-Ipsiroglu</surname><given-names>S</given-names></name></person-group><article-title>Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism</article-title><source>J Inherit Metab Dis</source><year>2003</year><volume>26</volume><fpage>299</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">12889668</pub-id><pub-id pub-id-type="doi">10.1023/A:1024453704800</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sykut-Cegielska</surname><given-names>J</given-names></name><name><surname>Gradowska</surname><given-names>W</given-names></name><name><surname>Mercimek-Mahmutoglu</surname><given-names>S</given-names></name><name><surname>St&#x000f6;ckler-Ipsiroglu</surname><given-names>S</given-names></name></person-group><article-title>Biochemical and clinical characteristics of creatine deficiency syndromes</article-title><source>Acta Biochim Pol</source><year>2004</year><volume>51</volume><fpage>875</fpage><lpage>882</lpage><pub-id pub-id-type="pmid">15625559</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wallimann</surname><given-names>T</given-names></name><name><surname>Wyss</surname><given-names>M</given-names></name><name><surname>Brdiczka</surname><given-names>D</given-names></name><name><surname>Nicolay</surname><given-names>K</given-names></name><name><surname>Eppenberger</surname><given-names>HM</given-names></name></person-group><article-title>Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis</article-title><source>Biochem J</source><year>1992</year><volume>281</volume><fpage>21</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">1731757</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wyss</surname><given-names>M</given-names></name><name><surname>Kaddurah-Daouk</surname><given-names>R</given-names></name></person-group><article-title>Creatine and creatinine metabolism</article-title><source>Physiol Rev</source><year>2000</year><volume>80</volume><fpage>1107</fpage><lpage>1213</lpage><pub-id pub-id-type="pmid">10893433</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Pilsum</surname><given-names>JF</given-names></name><name><surname>Stephens</surname><given-names>GC</given-names></name><name><surname>Taylor</surname><given-names>D</given-names></name></person-group><article-title>Distribution of creatine, guanidinoacetate and enzymes for their biosynthesis in the animal kingdom. Implications for phylogeny</article-title><source>Biochem J</source><year>1972</year><volume>126</volume><fpage>325</fpage><lpage>345</lpage></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Chae</surname><given-names>YJ</given-names></name><name><surname>Ogawa</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>MH</given-names></name><name><surname>Gerton</surname><given-names>GL</given-names></name></person-group><article-title>Creatine synthesis and transport systems in the male rat reproductive tract</article-title><source>Biol Reprod</source><year>1998</year><volume>58</volume><fpage>1437</fpage><lpage>1444</lpage><pub-id pub-id-type="pmid">9623603</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braissant</surname><given-names>O</given-names></name><name><surname>Henry</surname><given-names>H</given-names></name><name><surname>Loup</surname><given-names>M</given-names></name><name><surname>Eilers</surname><given-names>B</given-names></name><name><surname>Bachmann</surname><given-names>C</given-names></name></person-group><article-title>Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study</article-title><source>Mol Brain Res</source><year>2001</year><volume>86</volume><fpage>193</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">11165387</pub-id><pub-id pub-id-type="doi">10.1016/S0169-328X(00)00269-2</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guimbal</surname><given-names>C</given-names></name><name><surname>Kilimann</surname><given-names>MW</given-names></name></person-group><article-title>A Na<sup>+</sup>-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression</article-title><source>J Biol Chem</source><year>1993</year><volume>268</volume><fpage>8418</fpage><lpage>8421</lpage><pub-id pub-id-type="pmid">8473283</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schloss</surname><given-names>P</given-names></name><name><surname>Mayser</surname><given-names>W</given-names></name><name><surname>Betz</surname><given-names>H</given-names></name></person-group><article-title>The putative rat choline transporter CHOT1 transports creatine and is highly expressed in neural and muscle-rich tissues</article-title><source>Biochem Biophys Res Commun</source><year>1994</year><volume>198</volume><fpage>637</fpage><lpage>645</lpage><pub-id pub-id-type="pmid">8297374</pub-id><pub-id pub-id-type="doi">10.1006/bbrc.1994.1093</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Happe</surname><given-names>HK</given-names></name><name><surname>Murrin</surname><given-names>LC</given-names></name></person-group><article-title>In situ hybridization analysis of CHOT1, a creatine transporter, in the rat central nervous system</article-title><source>J Comp Neurol</source><year>1995</year><volume>351</volume><fpage>94</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">7896942</pub-id><pub-id pub-id-type="doi">10.1002/cne.903510109</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hiel</surname><given-names>H</given-names></name><name><surname>Happe</surname><given-names>HK</given-names></name><name><surname>Warr</surname><given-names>WB</given-names></name><name><surname>Morley</surname><given-names>BJ</given-names></name></person-group><article-title>Regional distribution of a creatine transporter in rat auditory brainstem: an in situ hybridization study</article-title><source>Hear Res</source><year>1996</year><volume>98</volume><fpage>29</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">8880179</pub-id><pub-id pub-id-type="doi">10.1016/0378-5955(96)00046-9</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saltarelli</surname><given-names>MD</given-names></name><name><surname>Bauman</surname><given-names>AL</given-names></name><name><surname>Moore</surname><given-names>KR</given-names></name><name><surname>Bradley</surname><given-names>CC</given-names></name><name><surname>Blakely</surname><given-names>RD</given-names></name></person-group><article-title>Expression of the rat brain creatine transporter in situ and in transfected HeLa cells</article-title><source>Dev Neurosci</source><year>1996</year><volume>18</volume><fpage>524</fpage><lpage>534</lpage><pub-id pub-id-type="pmid">8940628</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braissant</surname><given-names>O</given-names></name><name><surname>Henry</surname><given-names>H</given-names></name><name><surname>Villard</surname><given-names>AM</given-names></name><name><surname>Zurich</surname><given-names>MG</given-names></name><name><surname>Loup</surname><given-names>M</given-names></name><name><surname>Eilers</surname><given-names>B</given-names></name><name><surname>Parlascino</surname><given-names>G</given-names></name><name><surname>Matter</surname><given-names>E</given-names></name><name><surname>Boulat</surname><given-names>O</given-names></name><name><surname>Honegger</surname><given-names>P</given-names></name><name><surname>Bachmann</surname><given-names>C</given-names></name></person-group><article-title>Ammonium-induced impairment of axonal growth is prevented through glial creatine</article-title><source>J Neurosci</source><year>2002</year><volume>22</volume><fpage>9810</fpage><lpage>9820</lpage><pub-id pub-id-type="pmid">12427837</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohtsuki</surname><given-names>S</given-names></name><name><surname>Tachikawa</surname><given-names>M</given-names></name><name><surname>Takanaga</surname><given-names>H</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Hosoya</surname><given-names>K</given-names></name><name><surname>Terasaki</surname><given-names>T</given-names></name></person-group><article-title>The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain</article-title><source>J Cereb Blood Flow Metab</source><year>2002</year><volume>22</volume><fpage>1327</fpage><lpage>1335</lpage><pub-id pub-id-type="pmid">12439290</pub-id><pub-id pub-id-type="doi">10.1097/00004647-200211000-00006</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perasso</surname><given-names>L</given-names></name><name><surname>Cupello</surname><given-names>A</given-names></name><name><surname>Lunardi</surname><given-names>GL</given-names></name><name><surname>Principato</surname><given-names>C</given-names></name><name><surname>Gandolfo</surname><given-names>C</given-names></name><name><surname>Balestrino</surname><given-names>M</given-names></name></person-group><article-title>Kinetics of creatine in blood and brain after intraperitoneal injection in the rat</article-title><source>Brain Res</source><year>2003</year><volume>974</volume><fpage>37</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">12742622</pub-id><pub-id pub-id-type="doi">10.1016/S0006-8993(03)02547-2</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salomons</surname><given-names>GS</given-names></name><name><surname>van Dooren</surname><given-names>SJ</given-names></name><name><surname>Verhoeven</surname><given-names>NM</given-names></name><name><surname>Marsden</surname><given-names>D</given-names></name><name><surname>Schwartz</surname><given-names>C</given-names></name><name><surname>Cecil</surname><given-names>KM</given-names></name><name><surname>DeGrauw</surname><given-names>TJ</given-names></name><name><surname>Jakobs</surname><given-names>C</given-names></name></person-group><article-title>X-linked creatine transporter defect: an overview</article-title><source>J Inherit Metab Dis</source><year>2003</year><volume>26</volume><fpage>309</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">12889669</pub-id><pub-id pub-id-type="doi">10.1023/A:1024405821638</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sandell</surname><given-names>LL</given-names></name><name><surname>Guan</surname><given-names>XJ</given-names></name><name><surname>Ingram</surname><given-names>R</given-names></name><name><surname>Tilghman</surname><given-names>SM</given-names></name></person-group><article-title>Gatm, a creatine synthesis enzyme, is imprinted in mouse placenta</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>4622</fpage><lpage>4627</lpage><pub-id pub-id-type="pmid">12671064</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0230424100</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>A</given-names></name><name><surname>Marescau</surname><given-names>B</given-names></name><name><surname>Boehm</surname><given-names>EA</given-names></name><name><surname>Renema</surname><given-names>WK</given-names></name><name><surname>Peco</surname><given-names>R</given-names></name><name><surname>Das</surname><given-names>A</given-names></name><name><surname>Steinfeld</surname><given-names>R</given-names></name><name><surname>Chan</surname><given-names>S</given-names></name><name><surname>Wallis</surname><given-names>J</given-names></name><name><surname>Davidoff</surname><given-names>M</given-names></name><name><surname>Ullrich</surname><given-names>K</given-names></name><name><surname>Waldschutz</surname><given-names>R</given-names></name><name><surname>Heerschap</surname><given-names>A</given-names></name><name><surname>De Deyn</surname><given-names>PP</given-names></name><name><surname>Neubauer</surname><given-names>S</given-names></name><name><surname>Isbrandt</surname><given-names>D</given-names></name></person-group><article-title>Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency</article-title><source>Hum Mol Genet</source><year>2004</year><volume>13</volume><fpage>905</fpage><lpage>921</lpage><pub-id pub-id-type="pmid">15028668</pub-id><pub-id pub-id-type="doi">10.1093/hmg/ddh112</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>BM</given-names></name><name><surname>Miller</surname><given-names>RK</given-names></name><name><surname>Brent</surname><given-names>RL</given-names></name><name><surname>Koszalka</surname><given-names>TR</given-names></name></person-group><article-title>Materno-fetal transport of creatine in the rat</article-title><source>Biol Neonate</source><year>1978</year><volume>33</volume><fpage>43</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">656521</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>JB</given-names></name></person-group><article-title>Creatine: biosynthesis, regulation, and function</article-title><source>Adv Enzymol</source><year>1979</year><volume>50</volume><fpage>177</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">386719</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>GE</given-names></name><name><surname>Muhlebach</surname><given-names>S</given-names></name><name><surname>Moser</surname><given-names>A</given-names></name><name><surname>Masood</surname><given-names>R</given-names></name><name><surname>Paterson</surname><given-names>BM</given-names></name><name><surname>Buckingham</surname><given-names>ME</given-names></name><name><surname>Perriard</surname><given-names>JC</given-names></name></person-group><article-title>Developmental regulation of creatine kinase gene expression by myogenic factors in embryonic mouse and chick skeletal muscle</article-title><source>Development</source><year>1991</year><volume>113</volume><fpage>1017</fpage><lpage>1029</lpage><pub-id pub-id-type="pmid">1668275</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dickmeis</surname><given-names>T</given-names></name><name><surname>Rastegar</surname><given-names>S</given-names></name><name><surname>Aanstad</surname><given-names>P</given-names></name><name><surname>Clark</surname><given-names>M</given-names></name><name><surname>Fischer</surname><given-names>N</given-names></name><name><surname>Plessy</surname><given-names>C</given-names></name><name><surname>Rosa</surname><given-names>F</given-names></name><name><surname>Korzh</surname><given-names>V</given-names></name><name><surname>Strahle</surname><given-names>U</given-names></name></person-group><article-title>Expression of brain subtype creatine kinase in the zebrafish embryo</article-title><source>Mech Dev</source><year>2001</year><volume>109</volume><fpage>409</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">11731259</pub-id><pub-id pub-id-type="doi">10.1016/S0925-4773(01)00536-6</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>TJ</given-names></name><name><surname>Hanson</surname><given-names>RD</given-names></name><name><surname>Yancey</surname><given-names>PH</given-names></name></person-group><article-title>Developmental changes in organic osmolytes in prenatal and postnatal rat tissues</article-title><source>Comp Biochem Physiol A Mol Integr Physiol</source><year>2000</year><volume>125</volume><fpage>45</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">10779730</pub-id><pub-id pub-id-type="doi">10.1016/S1095-6433(99)00160-9</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kreis</surname><given-names>R</given-names></name><name><surname>Hofmann</surname><given-names>L</given-names></name><name><surname>Kuhlmann</surname><given-names>B</given-names></name><name><surname>Boesch</surname><given-names>C</given-names></name><name><surname>Bossi</surname><given-names>E</given-names></name><name><surname>Huppi</surname><given-names>PS</given-names></name></person-group><article-title>Brain metabolite composition during early human brain development as measured by quantitative in vivo <sup>1</sup>H magnetic resonance spectroscopy</article-title><source>Magn Reson Med</source><year>2002</year><volume>48</volume><fpage>949</fpage><lpage>958</lpage><pub-id pub-id-type="pmid">12465103</pub-id><pub-id pub-id-type="doi">10.1002/mrm.10304</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koszalka</surname><given-names>TR</given-names></name><name><surname>Jensh</surname><given-names>RP</given-names></name><name><surname>Brent</surname><given-names>RL</given-names></name></person-group><article-title>Placental transport of creatine in the rat</article-title><source>Proc Soc Exp Biol Med</source><year>1975</year><volume>148</volume><fpage>864</fpage><lpage>869</lpage><pub-id pub-id-type="pmid">1129310</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Meininger</surname><given-names>CJ</given-names></name><name><surname>Knabe</surname><given-names>DA</given-names></name><name><surname>Bazer</surname><given-names>FW</given-names></name><name><surname>Rhoads</surname><given-names>JM</given-names></name></person-group><article-title>Arginine nutrition in development, health and disease</article-title><source>Curr Opin Clin Nutr Metab Care</source><year>2000</year><volume>3</volume><fpage>59</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">10642085</pub-id><pub-id pub-id-type="doi">10.1097/00075197-200001000-00010</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>K</given-names></name><name><surname>Nakatsu</surname><given-names>F</given-names></name><name><surname>Kashiwagi</surname><given-names>K</given-names></name><name><surname>Ohno</surname><given-names>H</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Igarashi</surname><given-names>K</given-names></name></person-group><article-title>Essential role of S-adenosylmethionine decarboxylase in mouse embryonic development</article-title><source>Genes Cells</source><year>2002</year><volume>7</volume><fpage>41</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">11856372</pub-id><pub-id pub-id-type="doi">10.1046/j.1356-9597.2001.00494.x</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Mar</surname><given-names>MH</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Zeisel</surname><given-names>SH</given-names></name></person-group><article-title>Deletion of the Pemt gene increases progenitor cell mitosis, DNA and protein methylation and decreases calretinin expression in embryonic day 17 mouse hippocampus</article-title><source>Brain Res Dev Brain Res</source><year>2004</year><volume>149</volume><fpage>121</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">15063092</pub-id><pub-id pub-id-type="doi">10.1016/j.devbrainres.2004.01.004</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McGuire</surname><given-names>DM</given-names></name><name><surname>Tormanen</surname><given-names>CD</given-names></name><name><surname>Segal</surname><given-names>IS</given-names></name><name><surname>Van Pilsum</surname><given-names>JF</given-names></name></person-group><article-title>The effect of growth hormone and thyroxine on the amount of L-arginine:glycine amidinotransferase in kidneys of hypophysectomized rats. Purification and some properties of rat kidney transamidinase</article-title><source>J Biol Chem</source><year>1980</year><volume>255</volume><fpage>1152</fpage><lpage>1159</lpage><pub-id pub-id-type="pmid">6766137</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guthmiller</surname><given-names>P</given-names></name><name><surname>Van Pilsum</surname><given-names>JF</given-names></name><name><surname>Boen</surname><given-names>JR</given-names></name><name><surname>McGuire</surname><given-names>DM</given-names></name></person-group><article-title>Cloning and sequencing of rat kidney L-arginine:glycine amidinotransferase. Studies on the mechanism of regulation by growth hormone and creatine</article-title><source>J Biol Chem</source><year>1994</year><volume>269</volume><fpage>17556</fpage><lpage>17560</lpage><pub-id pub-id-type="pmid">8021264</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JJ</given-names></name></person-group><article-title>Immunocytochemical demonstration of the binding of growth-related polypeptide hormones on chick embryonic tissues</article-title><source>Histochemistry</source><year>1989</year><volume>93</volume><fpage>133</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">2613553</pub-id><pub-id pub-id-type="doi">10.1007/BF00315966</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muscat</surname><given-names>GE</given-names></name><name><surname>Downes</surname><given-names>M</given-names></name><name><surname>Dowhan</surname><given-names>DH</given-names></name></person-group><article-title>Regulation of vertebrate muscle differentiation by thyroid hormone: the role of the myoD gene family</article-title><source>Bioessays</source><year>1995</year><volume>17</volume><fpage>211</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">7748175</pub-id><pub-id pub-id-type="doi">10.1002/bies.950170307</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>CD</given-names></name><name><surname>Sanders</surname><given-names>EJ</given-names></name></person-group><article-title>Extra-pituitary growth hormone in peripheral tissues of early chick embryos</article-title><source>J Endocrinol</source><year>2000</year><volume>166</volume><fpage>489</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">10974643</pub-id><pub-id pub-id-type="doi">10.1677/joe.0.1660489</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luna</surname><given-names>M</given-names></name><name><surname>Huerta</surname><given-names>L</given-names></name><name><surname>Berumen</surname><given-names>L</given-names></name><name><surname>Martinez-Coria</surname><given-names>H</given-names></name><name><surname>Harvey</surname><given-names>S</given-names></name><name><surname>Aramburo</surname><given-names>C</given-names></name></person-group><article-title>Growth hormone in the male reproductive tract of the chicken: heterogeneity and changes during ontogeny and maturation</article-title><source>Gen Comp Endocrinol</source><year>2004</year><volume>137</volume><fpage>37</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">15094334</pub-id><pub-id pub-id-type="doi">10.1016/j.ygcen.2004.02.005</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname><given-names>GS</given-names></name><name><surname>Krahe</surname><given-names>R</given-names></name><name><surname>Goodwin</surname><given-names>LA</given-names></name><name><surname>Doggett</surname><given-names>NA</given-names></name><name><surname>Siciliano</surname><given-names>MJ</given-names></name><name><surname>Funanage</surname><given-names>VL</given-names></name><name><surname>Proujansky</surname><given-names>R</given-names></name></person-group><article-title>Identification of a testis-expressed creatine transporter gene at 16p11.2 and confirmation of the X-linked locus to Xq28</article-title><source>Genomics</source><year>1996</year><volume>34</volume><fpage>143</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">8661037</pub-id><pub-id pub-id-type="doi">10.1006/geno.1996.0254</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eichler</surname><given-names>EE</given-names></name><name><surname>Lu</surname><given-names>F</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Antonacci</surname><given-names>R</given-names></name><name><surname>Jurecic</surname><given-names>V</given-names></name><name><surname>Doggett</surname><given-names>NA</given-names></name><name><surname>Moyzis</surname><given-names>RK</given-names></name><name><surname>Baldini</surname><given-names>A</given-names></name><name><surname>Gibbs</surname><given-names>RA</given-names></name><name><surname>Nelson</surname><given-names>DL</given-names></name></person-group><article-title>Duplication of a gene-rich cluster between 16p11.1 and Xq28: a novel pericentromeric-directed mechanism for paralogous genome evolution</article-title><source>Hum Mol Genet</source><year>1996</year><volume>5</volume><fpage>899</fpage><lpage>912</lpage><pub-id pub-id-type="pmid">8817324</pub-id><pub-id pub-id-type="doi">10.1093/hmg/5.7.899</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dziegielewska</surname><given-names>KM</given-names></name><name><surname>Ek</surname><given-names>J</given-names></name><name><surname>Habgood</surname><given-names>MD</given-names></name><name><surname>Saunders</surname><given-names>NR</given-names></name></person-group><article-title>Development of the choroid plexus</article-title><source>Microsc Res Tech</source><year>2001</year><volume>52</volume><fpage>5</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">11135444</pub-id><pub-id pub-id-type="doi">10.1002/1097-0029(20010101)52:1&#x0003c;5::AID-JEMT3&#x0003e;3.0.CO;2-J</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Engelhardt</surname><given-names>B</given-names></name></person-group><article-title>Development of the blood-brain barrier</article-title><source>Cell Tissue Res</source><year>2003</year><volume>314</volume><fpage>119</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">12955493</pub-id><pub-id pub-id-type="doi">10.1007/s00441-003-0751-z</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Segal</surname><given-names>MB</given-names></name></person-group><article-title>The choroid plexuses and the barriers between the blood and the cerebrospinal fluid</article-title><source>Cell Mol Neurobiol</source><year>2000</year><volume>20</volume><fpage>183</fpage><lpage>196</lpage><pub-id pub-id-type="pmid">10696509</pub-id><pub-id pub-id-type="doi">10.1023/A:1007045605751</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peral</surname><given-names>MJ</given-names></name><name><surname>Galvez</surname><given-names>M</given-names></name><name><surname>Soria</surname><given-names>ML</given-names></name><name><surname>Ilundain</surname><given-names>AA</given-names></name></person-group><article-title>Developmental decrease in rat small intestinal creatine uptake</article-title><source>Mech Ageing Dev</source><year>2005</year><volume>126</volume><fpage>523</fpage><lpage>530</lpage><pub-id pub-id-type="pmid">15722111</pub-id><pub-id pub-id-type="doi">10.1016/j.mad.2004.11.005</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Groenen</surname><given-names>PM</given-names></name><name><surname>Engelke</surname><given-names>UF</given-names></name><name><surname>Wevers</surname><given-names>RA</given-names></name><name><surname>Hendriks</surname><given-names>JC</given-names></name><name><surname>Eskes</surname><given-names>TK</given-names></name><name><surname>Merkus</surname><given-names>HM</given-names></name><name><surname>Steegers-Theunissen</surname><given-names>RP</given-names></name></person-group><article-title>High-resolution 1H NMR spectroscopy of amniotic fluids from spina bifida fetuses and controls</article-title><source>Eur J Obstet Gynecol Reprod Biol</source><year>2004</year><volume>112</volume><fpage>16</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">14687733</pub-id><pub-id pub-id-type="doi">10.1016/S0301-2115(03)00279-3</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>St&#x000f6;ckler</surname><given-names>S</given-names></name><name><surname>Isbrandt</surname><given-names>D</given-names></name><name><surname>Hanefeld</surname><given-names>F</given-names></name><name><surname>Schmidt</surname><given-names>B</given-names></name><name><surname>Von Figura</surname><given-names>K</given-names></name></person-group><article-title>Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man</article-title><source>Am J Hum Genet</source><year>1996</year><volume>58</volume><fpage>914</fpage><lpage>922</lpage><pub-id pub-id-type="pmid">8651275</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ganesan</surname><given-names>V</given-names></name><name><surname>Johnson</surname><given-names>A</given-names></name><name><surname>Connelly</surname><given-names>A</given-names></name><name><surname>Eckhardt</surname><given-names>S</given-names></name><name><surname>Surtees</surname><given-names>RA</given-names></name></person-group><article-title>Guanidinoacetate methyltransferase deficiency: new clinical features</article-title><source>Pediatr Neurol</source><year>1997</year><volume>17</volume><fpage>155</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">9367297</pub-id><pub-id pub-id-type="doi">10.1016/S0887-8994(97)00083-0</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schulze</surname><given-names>A</given-names></name><name><surname>Mayatepek</surname><given-names>E</given-names></name><name><surname>Bachert</surname><given-names>P</given-names></name><name><surname>Marescau</surname><given-names>B</given-names></name><name><surname>De Deyn</surname><given-names>PP</given-names></name><name><surname>Rating</surname><given-names>D</given-names></name></person-group><article-title>Therapeutic trial of arginine restriction in creatine deficiency syndrome</article-title><source>Eur J Pediatr</source><year>1998</year><volume>157</volume><fpage>606</fpage><lpage>607</lpage><pub-id pub-id-type="pmid">9686828</pub-id><pub-id pub-id-type="doi">10.1007/s004310050890</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cecil</surname><given-names>KM</given-names></name><name><surname>Salomons</surname><given-names>GS</given-names></name><name><surname>Ball</surname><given-names>WS</given-names></name><name><surname>Wong</surname><given-names>B</given-names></name><name><surname>Chuck</surname><given-names>G</given-names></name><name><surname>Verhoeven</surname><given-names>NM</given-names></name><name><surname>Jakobs</surname><given-names>C</given-names></name><name><surname>DeGrauw</surname><given-names>TJ</given-names></name></person-group><article-title>Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect?</article-title><source>Ann Neurol</source><year>2001</year><volume>49</volume><fpage>401</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">11261517</pub-id><pub-id pub-id-type="doi">10.1002/ana.79</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braissant</surname><given-names>O</given-names></name></person-group><article-title>Measurement of nitric oxide-related enzymes in brain by in situ hybridization</article-title><source>Meth Mol Biol</source><year>2004</year><volume>279</volume><fpage>113</fpage><lpage>224</lpage></citation></ref><ref id="B53"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Hebel</surname><given-names>R</given-names></name><name><surname>Stromberg</surname><given-names>MW</given-names></name></person-group><source>Anatomy and embryology of the laboratory rat</source><year>1986</year><publisher-name>W&#x000f6;rthsee: BioMed Verlag</publisher-name></citation></ref><ref id="B54"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Kaufman</surname><given-names>M</given-names></name></person-group><source>The atlas of mouse development</source><year>1992</year><publisher-name>London: Academic Press</publisher-name></citation></ref><ref id="B55"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Altman</surname><given-names>J</given-names></name><name><surname>Bayer</surname><given-names>S</given-names></name></person-group><source>Atlas of prenatal rat brain development</source><year>1995</year><publisher-name>Boca Raton: CRC Press Inc</publisher-name></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braissant</surname><given-names>O</given-names></name><name><surname>Gotoh</surname><given-names>T</given-names></name><name><surname>Loup</surname><given-names>M</given-names></name><name><surname>Mori</surname><given-names>M</given-names></name><name><surname>Bachmann</surname><given-names>C</given-names></name></person-group><article-title>Differential expression of the cationic amino acid transporter 2(B) in the adult rat brain</article-title><source>Mol Brain Res</source><year>2001</year><volume>91</volume><fpage>189</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">11457509</pub-id><pub-id pub-id-type="doi">10.1016/S0169-328X(01)00113-9</pub-id></citation></ref></ref-list></back></article> 